Generics Makers Fight Cert. In Cholesterol Drug Pricing MDL
By Gianna Ferrarin · January 26, 2026, 8:36 PM EST
Generic-drug makers sought to defeat a bid to certify proposed classes comprising thousands of pharmacies that indirectly purchased and resold generics at the center of sprawling price-fixing litigation, telling a Pennsylvania federal court Monday...
To view the full article, register now.